Insights

Strategic Collaboration Opportunity to partner with a cancer research institute focused on translating clinical data into mechanistic cancer insights. Potential alignment with biotech vendors, data integration platforms, and high-content single-cell analysis tools to support their translational research objectives.

Funding & Growth Current revenue range indicates a smaller, potentially grant- or contract-driven operation with room to scale via sponsored research, clinical partnerships, or service agreements. Target funding offices or university-affiliated innovation programs for joint grant opportunities.

Technology Fit Tech stack includes cloud, data orchestration, and analytics tools (Oracle Cloud, GraphQL, Linux, GitLab). Sales angles could center on scalable data management, secure cloud-based collaboration, and reproducible research pipelines.

Market Position Operating within a competitive cancer research ecosystem; potential to position as a specialized partner for translational science, imaging analytics, and single-cell data interpretation to complement larger cancer centers’ capabilities.

Talent & Engagement Small to mid-sized team (11-50 employees) suggests agility but limited internal capacity for broad project deployments. Opportunity to offer managed services, training, or co-development programs to extend capabilities without substantial hiring.

Similar companies to CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer

CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer Tech Stack

CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer uses 8 technology products and services including Autodesk Maya, Salesforce, Dropbox, and more. Explore CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's tech stack below.

  • Autodesk Maya
    Audio, Video, Graphics
  • Salesforce
    Customer Relationship Management
  • Dropbox
    Digital Asset Management
  • American Registry of Radiologic Technologists
    Education Management
  • Microsoft Intune
    Enterprise Mobility Management
  • Workday Student
    Human Resource Management System
  • Bash
    Operating Systems & Computing Languages
  • Language Integrated Query
    Programming Languages

Media & News

CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's Email Address Formats

CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer uses at least 1 format(s):
CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer Email FormatsExamplePercentage
First.Last@usc.eduJohn.Doe@usc.edu
60%
FLast@usc.eduJDoe@usc.edu
28%
Last@usc.eduDoe@usc.edu
7%
FirstL@usc.eduJohnD@usc.edu
5%

Frequently Asked Questions

What is CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's official website and social media links?

Minus sign iconPlus sign icon
CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's official website is usc.edu and has social profiles on LinkedIn.

What is CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's NAICS code?

Minus sign iconPlus sign icon
CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's NAICS code is 5417 - Scientific Research and Development Services.

How many employees does CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer have currently?

Minus sign iconPlus sign icon
As of August 2026, CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer has approximately 28 employees across 2 continents, including North AmericaEurope. Key team members include Director: D. T.Research Assistant: C. M.Project Manager / Gis Junior Analyst: I. H.. Explore CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's employee directory with LeadIQ.

What industry does CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer belong to?

Minus sign iconPlus sign icon
CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer operates in the Research Services industry.

What technology does CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer use?

Minus sign iconPlus sign icon
CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's tech stack includes Autodesk MayaSalesforceDropboxAmerican Registry of Radiologic TechnologistsMicrosoft IntuneWorkday StudentBashLanguage Integrated Query.

What is CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's email format?

Minus sign iconPlus sign icon
CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's email format typically follows the pattern of First.Last@usc.edu. Find more CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer email formats with LeadIQ.
CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer logo

CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer

Research ServicesCalifornia, United States11-50 Employees

CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer is a research entity based in Los Angeles, California, focused on integrating patient data, model systems, and high-content single-cell information to translate observed clinical correlations into a mechanistic understanding of cancer dynamics. Its work centers on examining the spatial distributions and temporal evolution of cancer across cellular, human, and population scales, with an emphasis on the physical dynamics underlying the disease. The organization operates within the research services space, collaborating to clarify how cancer progresses by linking diverse data types to fundamental biological and physical processes.

Section iconCompany Overview

Website
usc.edu
NAICS Code
5417 - Scientific Research and Development Services
Employees
11-50

Section iconFunding & Financials

  • $1M$10M

    CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    CSI-Cancer: USC Michelson Center Convergent Science Institute in Cancer's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.